Genetic testing first for chronic kidney disease
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether people with chronic kidney disease (CKD) should get genetic testing right away to find potential inherited causes. It aims to help patients and their families understand their kidney condition better and guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic kidney disease (CKD) and have been referred to a kidney doctor for further evaluation.
- You or your doctor think your kidney disease might have a genetic cause, based on a screening checklist.
- You (or your legal decision-maker) can understand the study and agree to join it.
- Family members can also join if you are enrolled and they give consent.
- Your healthcare provider must have referred at least one person to this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses genetic testing to find the cause of rare kidney diseases. It is for people with unexplained kidney problems, a family history of kidney disease, or certain findings on ultrasound. The goal is to provide a more personalized diagnosis and see if this approach is cost-effective.
This study uses genetic testing to look for inherited (“monogenic”) reasons some people get kidney stones. It may help explain the cause of stones and calcium-related problems, which can guide future care for you or your family.
This study looks at how genetics affect the progression of kidney diseases. Joining may help researchers understand your condition better and find better treatments.
This study looks at how genes affect kidney disease in people from diverse backgrounds. It may help researchers understand why some people get kidney disease and others don't, which could lead to better prevention and treatment.
This study looks at genetic features of kidney cancer by testing tumor samples. The goal is to find biomarkers—specific signs—that may help predict what kind of kidney cancer it is.
This study looks at genetic markers (genes) related to kidney risk in Black/African American adults. It may help researchers better understand who is at higher risk and how genetics could guide future care.
Hear when a new Chronic Kidney Disease(CKD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.